LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Relative Growth Rate After Treatment
MDA-MB-231 CP724714
0.37
uM
LJP5
 72
hr
 868 2643 3486 0.7583 0.6781
MDA-MB-231 CP466722
0.37
uM
LJP5
 72
hr
 868 3509 3486 1.0066 1.0088
MDA-MB-231 Crizotinib
0.37
uM
LJP5
 72
hr
 868 2400 3486 0.6884 0.5851
MDA-MB-231 Momelotinib
0.37
uM
LJP5
 72
hr
 868 2590 3486 0.7429 0.6576
MDA-MB-231 Dasatinib
0.37
uM
LJP5
 72
hr
 868 496 3486 0.1424 -0.1420
MDA-MB-231 Dasatinib
0.37
uM
LJP6
 72
hr
 868 545 3486 0.1563 -0.1234
MDA-MB-231 Dovitinib
0.37
uM
LJP5
 72
hr
 868 1891 3486 0.5425 0.3908
MDA-MB-231 Enzastaurin
0.37
uM
LJP5
 72
hr
 868 3475 3486 0.9969 0.9959
MDA-MB-231 Erlotinib
0.37
uM
LJP5
 72
hr
 868 3259 3486 0.9350 0.9134
MDA-MB-231 Foretinib
0.37
uM
LJP5
 72
hr
 868 1463 3486 0.4196 0.2272
MDA-MB-231 R406
0.37
uM
LJP6
 72
hr
 868 3030 3486 0.8692 0.8258
MDA-MB-231 Pictilisib
0.37
uM
LJP6
 72
hr
 868 2611 3486 0.7489 0.6657
MDA-MB-231 Gefitinib
0.37
uM
LJP6
 72
hr
 868 3668 3486 1.0522 1.0695
MDA-MB-231 Geldanamycin
0.37
uM
LJP5
 72
hr
 868 1240 3486 0.3558 0.1422
MDA-MB-231 Geldanamycin
0.37
uM
LJP6
 72
hr
 868 1323 3486 0.3795 0.1737
MDA-MB-231 GSK1059615
0.37
uM
LJP5
 72
hr
 868 3113 3486 0.8929 0.8574
MDA-MB-231 GSK1059615
0.37
uM
LJP6
 72
hr
 868 3102 3486 0.8898 0.8533
MDA-MB-231 GSK1904529A
0.37
uM
LJP6
 72
hr
 868 3091 3486 0.8866 0.8490
MDA-MB-231 Omipalisib
0.37
uM
LJP6
 72
hr
 868 1278 3486 0.3667 0.1567
MDA-MB-231 GSK 690693
0.37
uM
LJP5
 72
hr
 868 3036 3486 0.8709 0.8281
MDA-MB-231 GW843682X
0.37
uM
LJP6
 72
hr
 868 1558 3486 0.4470 0.2636
MDA-MB-231 HG-5-113-01
0.37
uM
LJP5
 72
hr
 868 2123 3486 0.6090 0.4794
MDA-MB-231 HG-5-88-01
0.37
uM
LJP6
 72
hr
 868 2445 3486 0.7014 0.6024
MDA-MB-231 Imatinib
0.37
uM
LJP6
 72
hr
 868 3778 3486 1.0838 1.1116
MDA-MB-231 JNK-9L
0.37
uM
LJP6
 72
hr
 868 1999 3486 0.5736 0.4322